2024 Rsiv. Today, cdc updated its recommendation for the use of respiratory syncytial virus (rsv) vaccines in people ages 60 and older. Data center, space, iot, embedded and more.

Currently, the vaccines are approved for one dose because researchers are uncertain how long the vaccines will protect an individual, says dr. Die nachfrage ist hoch, doch vielerorts ist er mangelware.